Hepatoprotective effects of Spirulina maxima in patients with non

Hepatoprotective effects of Spirulina maxima in patients with non

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series Aldo Ferreira-Hermosillo , Patricia V Torres-Duran and Marco A Juarez-Oropeza Journal of Medical Case Reports 2010, 4: 103doi:10.1186/1752-1947-4-103 Published: 19 April 201 0 Abstract (provisional) Introduction Non-alcoholic fatty liver diseases range from simple statuses to non-alcoholic steatohepatitis. The "two hits" hypothesis is widely accepted for its pathogenesis: the first hit is an increased fat flux to the liver, which predisposes our patient to a second hit where increasing free fatty acid oxidation into the mitochondria leads to oxidative stress, lipoperoxidation and a chain reaction with increased ROS. Clinical indications include abdominal cramps, meteoric and fatigue. Most patients, however, are asymptomatic, and diagnosis is based on aminotransferase elevation and ultrasonography (or "brilliant liver"). Spiraling maxima has been experimentally proven to
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: possess in vivo and in vitro hepatoprotective properties by maintaining the liver lipid profile. This case report evaluates the hepatoprotective effects of orally supplied Spiraling maxima. Case presentation Three Hispanic Mexican patients (a 43-year-old man, a 77-year-old man and a 44-year-old woman) underwent ultrasonography and were treated with 4.5g/day of Spiraling maxima for three months. Their blood samples before and after the treatment determined triacylglycerols, total cholesterol, high-density lipoprotein cholesterol, and almandine aminotransferase and low-density lipoprotein cholesterol levels. The results were assessed using ultrasound. Conclusion Treatment had therapeutic effects as evidenced by ultrasonography and the aminotransferase data. Hypolipidemic effects were also shown. We conclude that Spiraling maxima may be considered an alternative treatment for patients with non-alcoholic fatty liver diseases and dyslipidemic disorder....
View Full Document

This note was uploaded on 05/25/2011 for the course CHEM 1 taught by Professor Shannon during the Spring '11 term at Brown Mackie College.

Ask a homework question - tutors are online